Concepedia

Marisse Asong

MA

3

Publications

277

Citations

3

H-Index

2023

Active since

Affiliations

Novo Nordisk (Denmark)(Current)

Marisse Asong is an author at Novo Nordisk (Denmark) specializing in diabetes, medicine, and clinical trials.

ORCID

Top concepts

Publications per year

2023–2023

3

Publications

3

Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial

Athena Philis‐Tsimikas, Marisse Asong, Edward Franek et al. · The Lancet Diabetes & Endocrinology · 2023 · 125 citations

, , +7

Once-Weekly Insulin Icodec vs Once-Daily Insulin Degludec in Adults With Insulin-Naive Type 2 Diabetes

Ildiko Lingvay, Marisse Asong, Cyrus Desouza et al. · JAMA · 2023 · 123 citations · Full text

Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes

Thomas R. Pieber, Marisse Asong, Gabriele Fluhr et al. · Diabetes Obesity and Metabolism · 2023 · 29 citations · Full text

Rows per page

1–3 of 3